(1) There is continued in existence the Therapeutic Goods Administration Account.
Note: The Account was established by subsection 5(3) of the Financial Management Legislation Amendment Act 1999 .
(2) The Account is a special account for the purposes of the Public Governance, Performance and Accountability Act 2013 .
(3) There must be credited to the Account amounts equal to:
(a) amounts received by the Commonwealth by way of annual registration charge, annual listing charge, annual charge for inclusion in the Register and annual licensing charge; and
(b) interest received by the Commonwealth from the investment of an amount standing to the credit of the Account; and
(c) money received by the Commonwealth in relation to property paid for after a debit from the Account; and
(d) money received by the Commonwealth for services provided or to be provided, by or on behalf of the Commonwealth, using amounts standing to the credit of the Account (including amounts received by way of fees payable under the regulations); and
(e) donations for the furtherance of a purpose of the Account that are received by the Commonwealth; and
(f) receipts relating to the recovery of debts (other than debts in respect of statutory fines and penalties) by the Commonwealth that are associated with expenditure of an amount standing to the credit of the Account.
Note: An Appropriation Act provides for amounts to be credited to a special account if any of the purposes of the special account is a purpose that is covered by an item in the Appropriation Act.
(4) The purposes of the Account are to make payments:
(a) to further the objects of this Act (as set out in section 4); and
(b) to enable the Commonwealth to participate in the international harmonisation of regulatory controls on therapeutic goods and other related activities.